Topline results from metastatic breast cancer phase 3 trial
Updated prostate cancer results show anti-tumour activity
Gesynta Pharma continues endometriosis work
First-in-human circular RNA therapy for radiation-induced xerostomia
Fast Track Designation for colorectal cancer treatment
AI helps predict which DNA sequences bind to each other
Boost for Niagen’s NAD+ programme
Base to Base biotech podcast 68: Water from air for pharma and beyond
New phase 1 data show potential for neurodegenerative disease treatment
Metabolic syndrome linked to faster brain ageing
Bowel cancer samples could boost understanding of other killer diseases
FDA clearance for non-muscle invasive bladder cancer treatment